1. ScholarBank@NUS

Han Kiat Ho

rp05986

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Han Kiat Ho
Variants
Ho, H.K.
Ho H.K
Ho, Han Kiat
Ho Han Kiat
 
Main Affiliation
 
Faculty
 
Email
phahohk@nus.edu.sg
 
Other emails
 

Publications

Results 1-12 of 12 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
1Jan-2014Vascular endothelial growth factor inhibitors and cognitive impairment: Evidence and controversiesNg, T.; Cheung, Y.T.; Ng, Q.S.; Ho, H.K. ; Chan, A. 
213-Jul-2021Turning threats into opportunities—Transforming pharmacy education for modern pharmacy practiceChui, Wai Keung ; Ho, Han Kiat ; Chai, Li Lin Christina ; Gallagher, Paul J 
32020Role of exosomes in cancer-related cognitive impairmentKoh, Y.Q.; Tan, C.J.; Toh, Y.L.; Sze, S.K.; Ho, H.K. ; Limoli, C.L.; Chan, A. 
4Apr-2013Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysisTeo, Y.L.; Ho, H.K. ; Chan, A. 
5Sep-2013Nanomaterial scaffolds for stem cell proliferation and differentiation in tissue engineeringZhao, C.; Tan, A.; Pastorin, G. ; Ho, H.K. 
62015Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: Current understanding, challenges and recommendationsTeo Y.L ; Ho H.K ; Chan A 
71-Feb-2015Mechanism-based inactivation of CYP450 enzymes: A case study of lapatinibHo, Han Kiat ; Chan, James Chun Yip; Hardy, Klarissa D.; Chan, Eric Chun Yong 
82015Mechanism-based inactivation of CYP450 enzymes: A case study of lapatinibHo H.K ; Chan J.C.Y; Hardy K.D., Chan E.C.Y.
9Jan-2014Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerationsHo, H.K. ; Yeo, A.H.L.; Kang, T.S. ; Chua, B.T.
10Dec-2013Carbon nanotubes for delivery of small molecule drugsWong, B.S.; Yoong, S.L.; Jagusiak, A.; Panczyk, T.; Ho, H.K. ; Ang, W.H. ; Pastorin, G. 
11Oct-2006Bioactivation and hepatotoxicity of nitroaromatic drugsBoelsterli, U.A. ; Ho, H.K. ; Zhou, S. ; Leow, K.Y.
121-Feb-2014Asian study of clopidogrel (ASCLOP) responsiveness: The contributions of genetic and non-genetic factorsTan, D.S.Y. ; Yeo, A.H.L.; Ho, H.K. ; Wee, H.L. ; Ong, H.Y.